MAPT and Parkinson disease: Likewise, the ratio of tau to α-synuclein in CSF has been claimed to be of high specificity in distinguishing PD from other parkinsonian syndromes or neurological controls (Parnetti et al., 2011; Heegaard et al., 2014).